| Immune Escape of Relapsed AML Cells after Allogeneic Transplantation PD Matthew J. Christopher, M.D., Ph.D., Allegra A. Petti, Ph.D., Michael P ... The New England Journal of Medicine, 2018 | 449 | 2018 |
| Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data V Mathews, B George, E Chendamarai, KM Lakshmi, S Desire, ... Journal of Clinical Oncology 28 (24), 3866-3871, 2010 | 314 | 2010 |
| Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia V Madan, P Shyamsunder, L Han, A Mayakonda, Y Nagata, ... Leukemia 30 (8), 1672-1681, 2016 | 162 | 2016 |
| Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell … R Thirugnanam, B George, E Chendamarai, KM Lakshmi, ... Biology of Blood and Marrow Transplantation 15 (11), 1479-1484, 2009 | 121 | 2009 |
| Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy E Chendamarai, P Balasubramanian, B George, A Viswabandya, ... Blood, The Journal of the American Society of Hematology 119 (15), 3413-3419, 2012 | 78 | 2012 |
| Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide V Mathews, E Chendamarai, B George, A Viswabandya, A Srivastava Mediterranean journal of hematology and infectious diseases 3 (1), 2011 | 65 | 2011 |
| Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance E Chendamarai, S Ganesan, AA Alex, V Kamath, SC Nair, AJ Nellickal, ... PloS one 10 (3), e0121912, 2015 | 46 | 2015 |
| Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia S Ganesan, AA Alex, E Chendamarai, N Balasundaram, HK Palani, ... Leukemia 30 (11), 2169-2178, 2016 | 45 | 2016 |
| Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells D Karpova, MP Rettig, J Ritchey, D Cancilla, S Christ, L Gehrs, ... The Journal of clinical investigation 129 (7), 2745-2759, 2019 | 41 | 2019 |
| Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different … P Markose, E Chendamarai, P Balasubramanian, SR Velayudhan, ... Leukemia & lymphoma 50 (12), 2092-2095, 2009 | 27 | 2009 |
| Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia R Abboud, E Chendamarai, MP Rettig, KM Trinkaus, PA Riedell, ... Haematologica 105 (8), e404, 2020 | 24 | 2020 |
| Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells JC Rimando, E Chendamarai, MP Rettig, R Jayasinghe, MJ Christopher, ... Blood 141 (14), 1718-1723, 2023 | 20 | 2023 |
| Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury Z Guo, C Valenzuela Ripoll, A Picataggi, DR Rawnsley, M Ozcan, ... Basic to Translational Science 8 (3), 340-355, 2023 | 20 | 2023 |
| International reporting scale of BCR-ABL1 fusion transcript in chronic myeloid leukemia: First report from India P Balasubramanian, E Chendamarai, P Markose, L Fletcher, S Branford, ... Acta Haematologica 127 (3), 135-142, 2012 | 10 | 2012 |
| Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia N Balasundaram, S Ganesan, E Chendamarai, HK Palani, ... Blood advances 6 (2), 652-663, 2022 | 9 | 2022 |
| Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization D Cancilla, MP Rettig, D Karpova, H Thakellapalli, M Singh, MJ Meyers, ... Blood Advances 8 (6), 1379-1383, 2024 | 8* | 2024 |
| Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice A Ghobadi, MP Rettig, MS Holt, JK Ritchey, K Kennerly, E Chendamarai, ... Blood, The Journal of the American Society of Hematology 131 (23), 2594-2596, 2018 | 8 | 2018 |
| ABCB6 RNA expression in leukemias—expression is low in acute promyelocytic leukemia and FLT3-ITD-positive acute myeloid leukemia A Abraham, S Karathedath, S Varatharajan, P Markose, E Chendamarai, ... Annals of hematology 93, 509-512, 2014 | 8 | 2014 |
| Arsenic trioxide resistance: more to it than mutations in PML-RARα AA Alex, E Chendamarai, S Ganesan, N Balasundaram, HK Palani, ... Blood 124 (21), 3605, 2014 | 5 | 2014 |
| Single Agent Arsenic Trioxide Regimen for the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Initial Results of a Multicenter Randomized Controlled Study From India … V Mathews, B George, F Jijina, C Ross, R Nair, S Apte, G Narayanan, ... Blood 114 (22), 2082, 2009 | 4 | 2009 |
